Repligen Corporation Share Price

Repligen Corporation Share Price

NASDAQ: RGEN | Micro Cap
$188.68
+$4.12 (2.23%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Repligen Corporation Stock Performance

Open
$187.26
Prev. Close
$184.56
Circuit Range
N/A
Day Range
$185.40 - $190.96
Year Range
$101.00 - $198.85
Volume
74,026
Average Traded
$188.13

Repligen Corporation Share Price Today

As of 30 October 2026, Repligen Corporation's share price is $188.68. The stock opened at $187.26, compared to its previous close of $184.56. During today's trading session, Repligen Corporation's share price traded between $185.40 and $190.96, with an average price of $188.18. Over the past 52 weeks, the stock has recorded a high of $198.85 and a low of $101.00. In terms of performance, Repligen Corporation's share price has risen by 59.44% over the last six months and is up 26.57% on a year-on-year basis.

Repligen Corporation Share Price Chart

Line chart of the Repligen Corporation price trend over the selected period. The price rose overall, ranging from 185.40 to 191.00, ending at 188.56.
$185.40$190.96
L
Show Current Price
H

Repligen Corporation Stock Fundamentals & Key Indicators

Market Cap
$10.61M
PE Ratio (TTM)
282.29
Dividend Yield
0.00%
EPS (TTM)
$0.65
Revenue (TTM)
$738.26B
Return On Equity (TTM)
1.97%
Profit Margin
6.62%
Debt to Equity
0.26
Quarterly Earnings Growth YoY
-66.40%

Repligen Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$188.81$197.91$194.26$204.13
Net Profit$14.91$13.29$8.33$5.01
Net Profit Margin7.90%6.72%4.29%2.45%
Income ChangeN/A-10.87%-37.32%-39.86%

Repligen Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$801.54$632.36$634.44$738.26
Net Profit$185.96$35.60-$25.51$48.89
Net Profit Margin23.20%5.63%-4.02%6.62%
Income ChangeN/A-80.86%-171.66%291.65%

About Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Repligen Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$190.84
$188.44
-2.09%
Sep 2026
$177.71
$192.47
+5.74%
Aug 2026
$143.66
$182.02
+29.01%
Jul 2026
$137.96
$141.09
+3.41%
Jun 2026
$122.00
$136.44
+10.08%
May 2026
$117.89
$123.95
+4.74%
Apr 2026
$118.70
$118.34
+0.40%
Mar 2026
$126.14
$117.87
-8.40%
Feb 2026
$150.25
$128.68
-13.74%
Jan 2026
$163.69
$149.18
-8.99%
Dec 2025
$169.89
$163.92
-4.03%
Nov 2025
$148.26
$170.81
+14.58%

RGEN Share Price FAQs